ARCHIVES

FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 12 | March 23, 2001

Download PDF Visit The Full Archive

Related Articles

Howard Hughes Medical Institute Seeks up to 25 New Researchers

January 17, 2014

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

May 30, 2014

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

NCI’s Schneiderman Reports Result Of Better Treatment, Some Drop In Incidence, Overall Increase As Kennedy Hearings Open

March 9, 1979

Standard Procedures Discarded in Review Of $20 Million in Texas Funds For Project Led by Wife of MD Anderson President

May 25, 2012